ANALIZE MEDICALE DE LABORATOR
Aici gasiti analizele medicale grupate pe categorii precum si detalii generale si specifice pentru categoriile respective.
Selectati o categorie din lista de mai jos:

Dictionar de medicamente online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Dictionar medical online

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Puteti trimite articole cu tema medicala la
adresa de email

Solutie antistress!
Construieste poduri :)
Joc, Construieste podul, Cargo Bridge

Prinde pisica neagra :)
Prinde pisica neagra- Chat Noir - Flash game

8th Annual Anti-Cancer Drug Discovery & Development Summit

Scientists and senior level management executives will gather to exchange the latest drug discovery and development techniques at the 8th Annual Anti-Cancer Drug Discovery & Development Summit on July 17-18, 2006 at the Hilton Boston Back Bay Hotel in Boston, MA.

Robert A. Weinberg, Ph.D., winner of the 2006 Landon-AACR Prizes for Basic and Translational Cancer Research, will present the opening keynote address titled "Mechanisms of Malignant Progression" and Jeffrey H. Hanke, Ph.D., Vice President, Cancer Research, AstraZeneca will present the industry keynote on "Inhibition of Tumor Angiogenesis by Targeting VEGF Receptor Function, Preclinical and Emerging Clinical Data."

This summit has been highly proclaimed as the premier information networking meeting in this space, this year's meeting will bring together the finest group of oncology experts from around the world to address the most promising avenues of investigation, according to the Strategic Research Institute.

This agenda offers the hottest and latest anti-cancer research on: 1) Targeted Therapeutics, 2) Antibody Derived Targets & Biologics, and 3) Angiogenesis.

Highlighted research programs include the following:

-- Targeting VEGF Pathway with mAb's and Small Molecules
-- EGF Pathway Inhibitors (Erlotinib and Cetuximab)
-- Emerging Approaches to Target the c-Met/ HGF Axis
-- Selective and Multi-Targeted Kinase Inhibitors
-- Novel Biologicals (CD20, CTLA4, Angiopoietins, PSCA, SDF and Eph)
-- Emerging Data on Inhibitors of Mek, Hedgehog, CDK and HDAC

Complete list of participating companies and institutions includes:

Agensys, Amgen, Arqule, Array Biopharma, Astrazeneca, Chemokine Therapeutics, Compound Therapeutics, Curagen, Curis, Dana-Farber Cancer Institute, Exelixis, Genentech, Genmab A/S, Harvard University, Hoffmann-La Roche, Immunogen, Ludwig Center for Cancer Research, MD Anderson Cancer Center, Medarex, Medimmune, MIT, OSI Pharmaceuticals, Pfizer, Sunesis, Sherris Pharma Partners, University of Texas and Whitehead Institute.

Strategic Research Institute
http://www.srinstitute.com
http://www.srinstitute.com/cancer





8a anual Anti-Cancer Drug Discovery & Development Summit-ul de - 8th Annual Anti-Cancer Drug Discovery & Development Summit - articole medicale engleza - startsanatate